Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke

被引:85
作者
Savitz, SI [1 ]
Schlaug, G [1 ]
Caplan, L [1 ]
Selim, M [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cerebrovasc Dis, Boston, MA 02215 USA
关键词
gender; outcome; stroke; thrombolysis;
D O I
10.1161/01.STR.0000170647.42126.a8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - Previous reports suggest that women achieve better outcome than men after intravenous thrombolysis for ischemic stroke. Coagulation and fibrinolysis differ between sexes. These findings prompted us to investigate possible gender differences in arterial recanalization after intravenous tissue plasminogen activator (IV tPA). Methods - We identified 100 consecutive patients who presented with acute ischemic stroke and received IV tPA within 6 hours of onset. Only patients with large artery anterior circulation strokes, as determined by MRI/MRA or CT/CTA before treatment, who had follow-up vascular study within 72 hour after treatment were included. We compared demographics, clinical features, admission medications, symptom-to-needle and treatment-to-repeat vascular imaging times, baseline National Institutes of Health Stroke Severity score, radiological and laboratory data, stroke mechanism, and outcome between the sexes. Results - 39 patients met all inclusion/exclusion criteria (22 men and 17 women). The recanalization rate was significantly higher in women (94 % versus 59 %; P = 0.02). This difference remained statistically significant after excluding patients whose strokes were attributed to internal carotid artery occlusive lesions, and when the analysis was limited to those treated within 3 hours of stroke onset. All other confounding variables did not differ significantly between the sexes. Conclusions - In our cohort, vascular occlusive lesions were more likely to recanalize in women than men in response to IV tPA. These preliminary findings need to be validated in larger prospective studies.
引用
收藏
页码:1447 / 1451
页数:5
相关论文
共 30 条
  • [1] NON-INVASIVE TRANSCRANIAL DOPPLER ULTRASOUND RECORDING OF FLOW VELOCITY IN BASAL CEREBRAL-ARTERIES
    AASLID, R
    MARKWALDER, TM
    NORNES, H
    [J]. JOURNAL OF NEUROSURGERY, 1982, 57 (06) : 769 - 774
  • [2] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [3] Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Broderick, J
    Lu, M
    Jackson, C
    Pancioli, A
    Tilley, BC
    Fagan, SC
    Kothari, R
    Levine, SR
    Marler, JR
    Lyden, PD
    Haley, EC
    Brott, T
    Grotta, JC
    [J]. ANNALS OF NEUROLOGY, 2001, 49 (06) : 736 - 744
  • [4] Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial
    Clark, WM
    Wissman, S
    Albers, GW
    Jhamandas, JH
    Madden, KP
    Hamilton, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2019 - 2026
  • [5] Specific transcranial Doppler flow findings related to the presence and site of arterial occlusion
    Demchuk, AM
    Christou, I
    Wein, TH
    Felberg, RA
    Malkoff, M
    Grotta, JC
    Alexandrov, AV
    [J]. STROKE, 2000, 31 (01) : 140 - 146
  • [6] FIBRINOGEN - ITS EMERGING ROLE AS A CARDIOVASCULAR RISK FACTOR
    ERNST, E
    [J]. ANGIOLOGY, 1994, 45 (02) : 87 - 93
  • [7] Early dramatic recovery during intravenous tissue plasminogen activator infusion - Clinical pattern and outcome in acute middle cerebral artery stroke
    Felberg, RA
    Okon, NJ
    El-Mitwalli, A
    Burgin, WS
    Grotta, JC
    Alexandrov, AV
    [J]. STROKE, 2002, 33 (05) : 1301 - 1307
  • [8] ASSOCIATION BETWEEN INCREASED ESTROGEN STATUS AND INCREASED FIBRINOLYTIC POTENTIAL IN THE FRAMINGHAM OFFSPRING STUDY
    GEBARA, OCE
    MITTLEMAN, MA
    SUTHERLAND, P
    LIPINSKA, I
    MATHENEY, T
    XU, P
    WELTY, FK
    WILSON, PWF
    LEVY, D
    MULLER, JE
    TOFLER, GH
    [J]. CIRCULATION, 1995, 91 (07) : 1952 - 1958
  • [9] Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
    Hacke, W
    Kaste, M
    Fieschi, C
    von Kummer, R
    Davalos, A
    Meier, D
    Larrue, V
    Bluhmki, E
    Davis, S
    Donnan, G
    Schneider, D
    Diez-Tejedor, E
    Trouillas, P
    [J]. LANCET, 1998, 352 (9136) : 1245 - 1251
  • [10] HORITA K, 1993, ARTERY, V20, P324